Credelio Plus 56.25 mg/2.11 mg Chewable Tablets for Dogs (1.4 kg - 2.8 kg)

Nazione: Regno Unito

Lingua: inglese

Fonte: VMD (Veterinary Medicines Directorate)

Principio attivo:

Lotilaner, Milbemycin Oxime (A3 and A4)

Commercializzato da:

Elanco GmbH

Codice ATC:

QP54AB51

INN (Nome Internazionale):

Lotilaner, Milbemycin Oxime (A3 and A4)

Forma farmaceutica:

Chewable tablet

Tipo di ricetta:

POM-V - Prescription Only Medicine – Veterinarian

Gruppo terapeutico:

Dogs

Area terapeutica:

Endectocide

Stato dell'autorizzazione:

Authorized

Data dell'autorizzazione:

2021-03-29

Scheda tecnica

Revised: February 2023
AN: 01144/2022
Page 1 of 9
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Credelio Plus 56.25 mg/2.11 mg chewable tablets for dogs (1.4–2.8
kg)
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCES:
Each chewable tablet contains:
CREDELIO PLUS TABLETS
LOTILANER
MILBEMYCIN OXIME
Dogs (1.4‒2.8 kg)
56.25 mg
2.11 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Chewable tablet.
White to beige round biconvex chewable tablet with brownish spots and
bevelled edges with letter “I” debossed on one side of the tablet.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For use in dogs with, or at risk from, mixed infestations/infections
of ticks, fleas,
mites, gastrointestinal nematodes, heartworm and/or lungworm.
This veterinary medicinal product is indicated for use when treatment
against
ticks/fleas/mites and gastrointestinal nematodes or the treatment
against
ticks/fleas/mites and prevention of heartworm
disease/angiostrongylosis is
required concurrently.
Ectoparasites
For the treatment of tick (_Dermacentor reticulatus, Ixodes ricinus,
Rhipicephalus _
_sanguineus _and _I. hexagonus_) and flea (_Ctenocephalides felis _and
_C. canis_)
infestations in dogs.
This veterinary medicinal product provides immediate and persistent
killing
Revised: February 2023
AN: 01144/2022
Page 2 of 9
activity for 1 month for ticks and fleas.
The veterinary medicinal product can be used as part of a treatment
strategy for
the control of flea allergy dermatitis (FAD).
For the treatment of demodicosis (caused by _Demodex canis_).
Gastrointestinal Nematodes
Treatment of gastrointestinal nematodes: hookworm (L4, immature adult
(L5)
and adult _Ancylostoma caninum_), roundworms (L4, immature adult (L5)
and
adult _Toxocara canis_, and adult _Toxascaris leonina_) and whipworm
(adult
_Trichuris vulpis_).
Heartworm
Prevention of heartworm disease (_Dirofilaria immitis_).
Lungworm
Prevention of angiostrong